![]() H-Tyr-D-Ala-Gly-Phe-Met-NH2结构式
![]() |
常用名 | H-Tyr-D-Ala-Gly-Phe-Met-NH2 | 英文名 | H-Tyr-D-Ala-Gly-Phe-Met-NH2 |
---|---|---|---|---|
CAS号 | 61090-95-7 | 分子量 | 586.70300 | |
密度 | 1.286 g/cm3 | 沸点 | 1057.4ºC at 760 mmHg | |
分子式 | C28H38N6O6S | 熔点 | N/A | |
MSDS | N/A | 闪点 | 593.3ºC |
H-Tyr-D-Ala-Gly-Phe-Met-NH2用途本网站展示的所有产品仅用作科学研究,不可食用,不可用于人体或动物的临床诊断和治疗。
[D-Ala2]-Met-脑啡肽是一种阿片肽,是一种有效的阿片激动剂。[D-Ala2]-Met-脑啡肽通过中枢机制降低胆汁流量。[D-Ala2]-Met-脑啡肽具有镇痛作用[1][2]。 |
英文名 | 2-[[2-[[2-[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoylamino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide |
---|---|
英文别名 | 更多 |
描述 | [D-Ala2]-Met-脑啡肽是一种阿片肽,是一种有效的阿片激动剂。[D-Ala2]-Met-脑啡肽通过中枢机制降低胆汁流量。[D-Ala2]-Met-脑啡肽具有镇痛作用[1][2]。 |
---|---|
相关类别 | |
体内研究 | [D-Ala2]-Met-脑啡肽通过一种中枢机制降低Sprague-Dawley大鼠的胆汁流量[1]。动物模型:雄性Sprague-Dawley大鼠(250-320 g)[1]剂量:10、50、100、150和200 mg/kg给药:脑室内注射结果:胆汁流量减少12%至41%。胆汁中碳酸氢盐分泌减少。 |
密度 | 1.286 g/cm3 |
---|---|
沸点 | 1057.4ºC at 760 mmHg |
分子式 | C28H38N6O6S |
分子量 | 586.70300 |
闪点 | 593.3ºC |
精确质量 | 586.25700 |
PSA | 231.04000 |
LogP | 2.29780 |
折射率 | 1.601 |
~% H-Tyr-D-Ala-Gly... 61090-95-7 |
文献:Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
~% H-Tyr-D-Ala-Gly... 61090-95-7 |
文献:Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
~% H-Tyr-D-Ala-Gly... 61090-95-7 |
文献:Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
~% H-Tyr-D-Ala-Gly... 61090-95-7 |
文献:Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
~% H-Tyr-D-Ala-Gly... 61090-95-7 |
文献:Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
~% H-Tyr-D-Ala-Gly... 61090-95-7 |
文献:Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
~% H-Tyr-D-Ala-Gly... 61090-95-7 |
文献:Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
~% H-Tyr-D-Ala-Gly... 61090-95-7 |
文献:Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
~% H-Tyr-D-Ala-Gly... 61090-95-7 |
文献:Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
H-Tyr-D-Ala-Gly-Phe-Met-NH2上游产品 9 | |
---|---|
H-Tyr-D-Ala-Gly-Phe-Met-NH2下游产品 3 | |
DAME |
[D-Ala2]Met-enkephalinamide |
D-Enkephalin |
Met-enkephalinamide,ala(2) |
[D-Ala2-Met5]enkephalinamide |
Methionine-enkephalinamide,ala(2) |
Enkephalinamide-met,ala(2) |
Tyr-D-Ala-Gly-Phe-Met-NH2 |
Dalamid |
Dalamide |
2-Ala-met-enkephalinamide |
Enkephalinamide-met,alanine(2) |
[D-Ala2]-methionine enkephalinamide |
H-Tyr-D-Ala-Gly-Phe-Met-NH2 |
Enkephalin, Amide-[D-Ala2, Met5] |